NASDAQ:GOCO GoHealth (GOCO) Stock Price, News & Analysis $7.18 -0.57 (-7.35%) Closing price 04:00 PM EasternExtended Trading$7.32 +0.14 (+1.88%) As of 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About GoHealth Stock (NASDAQ:GOCO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get GoHealth alerts:Sign Up Key Stats Today's Range$7.17▼$7.7950-Day Range$7.75▼$16.0452-Week Range$7.11▼$21.00Volume73,512 shsAverage Volume38,235 shsMarket Capitalization$165.20 millionP/E RatioN/ADividend YieldN/APrice Target$13.00Consensus RatingHold Company OverviewGoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. It provides Medicare plans, including Medicare Advantage, Medicare Supplement and Prescription Drug, and Medicare Special Needs Plans. The company also offers partner marketing services. It sells its products through carriers and online platform, as well as independent and external agencies. The company was founded in 2001 and is headquartered in Chicago, Illinois.Read More… GoHealth Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks46th Percentile Overall ScoreGOCO MarketRank™: GoHealth scored higher than 46% of companies evaluated by MarketBeat, and ranked 586th out of 949 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingGoHealth has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageGoHealth has received no research coverage in the past 90 days.Read more about GoHealth's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for GoHealth are expected to grow in the coming year, from ($5.50) to ($3.91) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of GoHealth is -2.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of GoHealth is -2.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioGoHealth has a P/B Ratio of 0.40. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about GoHealth's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.14% of the float of GoHealth has been sold short.Short Interest Ratio / Days to CoverGoHealth has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in GoHealth has recently decreased by 1.67%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldGoHealth does not currently pay a dividend.Dividend GrowthGoHealth does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.14% of the float of GoHealth has been sold short.Short Interest Ratio / Days to CoverGoHealth has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in GoHealth has recently decreased by 1.67%, indicating that investor sentiment is improving. News and Social Media1.1 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 5 news articles for GoHealth this week, compared to 1 article on an average week.Search Interest1 people have searched for GOCO on MarketBeat in the last 30 days. MarketBeat Follows1 people have added GoHealth to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, GoHealth insiders have not sold or bought any company stock.Percentage Held by Insiders35.01% of the stock of GoHealth is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 24.21% of the stock of GoHealth is held by institutions.Read more about GoHealth's insider trading history. Receive GOCO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GoHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address GOCO Stock News HeadlinesINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. ...May 6 at 3:11 PM | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. - GOCOMay 6 at 2:04 PM | prnewswire.comURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. May 6, 2025 | Golden Portfolio (Ad)INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth, Inc. - GOCOMay 5 at 12:25 PM | globenewswire.comGOCO INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into GoHealth, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the FirmMay 2, 2025 | globenewswire.comGoHealth Extends CEO Vijay Kotte’s Contract and CompensationApril 7, 2025 | tipranks.comRBC Capital Keeps Their Hold Rating on GoHealth (GOCO)March 11, 2025 | markets.businessinsider.comGoHealth, Inc.: GoHealth Reports Strong Fourth Quarter and Fiscal Year 2024 Results, Driven by a Successful Annual Enrollment PeriodFebruary 28, 2025 | finanznachrichten.deSee More Headlines GOCO Stock Analysis - Frequently Asked Questions How have GOCO shares performed this year? GoHealth's stock was trading at $13.39 at the start of the year. Since then, GOCO stock has decreased by 46.4% and is now trading at $7.18. View the best growth stocks for 2025 here. How were GoHealth's earnings last quarter? GoHealth, Inc. (NASDAQ:GOCO) posted its quarterly earnings results on Thursday, November, 7th. The company reported ($3.73) earnings per share for the quarter, missing analysts' consensus estimates of ($3.19) by $0.54. The company earned $118.29 million during the quarter, compared to the consensus estimate of $105.93 million. GoHealth had a negative net margin of 4.32% and a negative trailing twelve-month return on equity of 17.17%. Read the conference call transcript. When did GoHealth IPO? GoHealth (GOCO) raised $750 million in an initial public offering (IPO) on Wednesday, July 15th 2020. The company issued 39,500,000 shares at $18.00-$20.00 per share. Goldman Sachs, BofA Securities and Morgan Stanley acted as the underwriters for the IPO and Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair, Cantor, SunTrust Robinson Humphrey and Loop Capital Markets were co-managers. Who are GoHealth's major shareholders? GoHealth's top institutional shareholders include FNY Investment Advisers LLC (0.01%). Insiders that own company stock include Cayman Gp Ltd Ccp III, Blizzard Holdings C LP Cb, Vijay Kotte and Jason Schulz. View institutional ownership trends. How do I buy shares of GoHealth? Shares of GOCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of GoHealth own? Based on aggregate information from My MarketBeat watchlists, some other companies that GoHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Invesco QQQ (QQQ), Tesla (TSLA), Netflix (NFLX) and Intel (INTC). Company Calendar Last Earnings11/07/2024Today5/06/2025Next Earnings (Estimated)5/08/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Insurance agents, brokers, & service Sub-IndustryInsurance Current SymbolNASDAQ:GOCO CIK1808220 Webwww.gohealth.com Phone312-386-8200FaxN/AEmployees5,450Year FoundedN/APrice Target and Rating Average Stock Price Target$13.00 High Stock Price Target$13.00 Low Stock Price Target$13.00 Potential Upside/Downside+81.1%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.72) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-63,260,000.00 Net Margins-4.32% Pretax Margin-9.81% Return on Equity-17.17% Return on Assets-4.58% Debt Debt-to-Equity Ratio1.72 Current Ratio1.18 Quick Ratio1.18 Sales & Book Value Annual Sales$798.89 million Price / Sales0.21 Cash Flow$1.18 per share Price / Cash Flow6.10 Book Value$18.06 per share Price / Book0.40Miscellaneous Outstanding Shares23,009,000Free Float14,887,000Market Cap$165.20 million OptionableNot Optionable Beta1.71 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:GOCO) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GoHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.